Secondary Logo

AAPA Members can view Full text articles for FREE. Not a Member? Join today!

Institutional members access full text with Ovid®

Adjuvant steroid therapy in community-acquired pneumonia

Sisson, Caroline Bell, MMS, PA-C

Journal of the American Academy of PAs: July 2017 - Volume 30 - Issue 7 - p 52–54
doi: 10.1097/01.JAA.0000520547.38699.83
What's New in Infectious Diseases
Buy

ABSTRACT Despite medical advances, pneumonia is a leading cause of death worldwide. Because inflammation is a key defense mechanism, adjuvant corticosteroid therapy has long been considered but never widely recommended to treat pneumonia. New research is exploring potential benefits of this therapy, including reduced time to clinical stability, reduced hospital stay, reduced rates of treatment failure, and prevention of complications.

Caroline Bell Sisson is an assistant professor in the PA program at Wake Forest School of Medicine in Winston-Salem, N.C., and affiliate professor in the College of Health Sciences at Appalachian State University in Boone, N.C. The author has disclosed no potential conflicts of interest, financial or otherwise.

Mark E. Archambault, DHSc, PA-C, department editor

Copyright © 2017 American Academy of Physician Assistants
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website